Program overview of Monday May 25

Monday’s program starts with a plenary session on Fat and Disease: Is it All About Triglycerides and is concluded with a session on The HDL Controversy. Furthermore the program contains eight interesting X-Change sessions and many other events, such as the Chinese and Russian Sessions and the I-Poster sessions, the Rapid Fire Sessions and the Innovation Theatre.

Plenary Sessions

Monday Morning Session

PlenarySessionFat and Disease: Is it All About Triglycerides?

Chairpersons: Lale Tokgozoglu (Ankara, Turkey) / Christie Ballantyne (Houston, USA)

08:30 – 09:00 Obesity & Hypertriglyceridemic Waist Jean-Pierre Després (Québec, Canada)
09:00 – 09:30 Triglyceridemia as Risk Factor for CVD Robert Hegele (London, Ontario, Canada)
09:30 – 10:00 Central Role of ApoC3 Ann Tybjaerg-Hansen (Copenhagen, Denmark)
10:00 – 10:30 Therapy of Hypertriglyceridemia Michael Davidson (Chicago, USA)

Monday Afternoon Session

PlenarySessionThe HDL Controversy: Is the Particle Irrelevant for Atherogenesis?

Chairpersons: Antonio Gotto (New York, USA) / Erik Stroes (Amsterdam, The Netherlands)

17:00 – 17:30 Biological Function of HDL Ulf Landmesser (Zürich, Switzerland)
17:30 – 18:00 HDL Plays No Role in the Pathogenesis of Atherosclerosis Børge Nordestgaard (Copenhagen, Denmark)

X-Changes sessions

Morning X-Change SessionsXchangeSession

9. Obesity & Visceral Fat

Chairpersons: Esther Lutgens (Amsterdam, The Netherlands) / Jean-Pierre Després (Québec, Canada)

Brown Adipose Tissue Patrick Rensen (Leiden, The Netherlands)
Inflammation of Visceral Fat Max Nieuwdorp (Amsterdam, The Netherlands)
Bariatric Surgery Rachel Batterham (London, UK)

10.Single Gene Disorders of Lipoprotein Metabolism 

Chairpersons: Eric Sijbrands (Rotterdam, The Netherlands) / Richard Češka (Prague, Czech Republic)

Hypotriglyceridemia / Hypertriglyceridemia Stephen Young (Los Angeles, USA)
Dysbetalipoproteinaemia: Mixed Hyperlipidaemia due to Remnants David Marais (Cape Town, South Africa)
Hypoalpha/Hyperalpha Jan Albert Kuivenhoven (Groningen, The Netherlands)
2x 10 minutes Selected Abstracts  

11. Familial Hypercholesterolemia 

Chairpersons: Raul Santos (Sao Paulo, Brazil) / Katherine Wilemon (South Pasadena, USA)

Homozygous FH & Apheresis Frederick Raal (Johannesburg, South Africa)
Heterozygous FH Kees Hovingh (Amsterdam, The Netherlands)
Why Early Recognition and Treatment of Familial Hypercholesterolemia is Critical Samuel Gidding (Wilmington/Philadelphia, USA)
2x 10 minutes Selected Abstracts  

12. New Insights Into Hypolipidaemic Drugs 

Chairpersons: Andrey Susekov (Moscow, Russia) / Sam Tsimikas (La Jolla, USA)

Statins & Nicotinic Acid Jane Armitage (Oxford, UK)
Lomitapide Mariko Harada-Shiba (Tokyo, Japan)
Mipomersen John Kastelein (Amsterdam, The Netherlands)
Absorption Inhibitors  

Afternoon X-Change SessionsXchangeSession

13. Reverse Cholesterol Transport

Chairpersons: Attilio Rigotti (Santiago, Chile) / Jan Albert Kuivenhoven (Groningen, The Netherlands)

HDL Mediated RCT Alan Tall (New York, USA)
Non-HDL Mediated RCT Bert Groen (Groningen, The Netherlands)
ApoA-I Mimetics to Increase RCT Alan Remaley (Bethesda, USA)
Probucol-mediated enhancement of reverse cholesterol transport for prevention of atherosclerosis Shizuya Yamashita (Osaka, Japan)

14. Novel Insights into Lp(a)

Chairpersons: Bülent Behlül Altunkeser (Konya, Turkey) / Robert Hegele (London, Ontario, Canada)

Epidemiology Pia Kamstrup (Copenhagen, Denmark)
Biology & Measurement Marlys Koschinsky (Windsor, Ontario, Canada)
Therapy Sam Tsimikas (La Jolla, USA)
Lp(a) Apheresis Marat Ezhov (Moscow, Russia) or Sergei Pokrovsky (Moscow, Russia)

15. HDL Functionality 

Chairpersons: Miranda van Eck (Leiden, The Netherlands) / Ruth Frikke Schmidt (Copenhagen, Denmark)

HDL Particle Composition & Function Kerry-Anne Rye (Sydney, Australia)
HDL Dysfunctionality in CAD Ulf Landmesser (Zurich, Switzerland)
The Endothelium as a Target and Barrier of HDL (dys)function Arnold von Eckardstein (Zürich, Switzerland)
2x 10 minutes Selected Abstracts  

16. Triglyceride-Rich Proteins

Chairpersons: Jacques Genest (Montreal, Canada) / Manuel Castro Cabezas (Rotterdam, The Netherlands)

Extreme Hypertriglyceridemia Daniel Gaudet (Montréal, Canada)
Triglyceride-Rich Lipoproteins as Drivers of Atherosclerosis Robert Hegele (London, Ontario, Canada)
Therapy Christie Ballantyne (Houston, USA)
2x 10 minutes Selected Abstracts  

 

Schedule of Monday 24 May

Stay up to date, subscribe to the newsletter

Progression and prevention of atherosclerosis and a translation to relevance.